First, the high level of CCR5 receptors on HLA-DR+ T-cells suggest that CCR5-antagonists such as maraviroc would be effective in reducing the HIV infection in these T-cells (Fatkenheuer et al., 2008; Rusconi et al., 2013). The gene discussed is CCR5; the disease is HIV infectious disease.